SEC Form 4 · accession 0001513162-15-000009
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $0.112 | Jan 2, 2015 | A | 400,000 | A | — | Jan 2, 2025 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1Right to buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan. Options vest and become exercisable in four (4) equal installments on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015.